CompletedNCT01220440
Methylphenidate, Dextroamphetamine, or Placebo for Children With ADHD
About this title
Read the official source — NCT01220440This study evaluated the effectiveness of Methylphenidate for people with ADHD.
Medication studyAges 9–14Norway
Understand this study
What did researchers investigate?
This study evaluated the effectiveness of Methylphenidate for people with ADHD.
Who was this study for?
Listed age limits: 9 years to 14 years.
- Listed locations
- Fredrikstad and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 36
- Sponsor
- Ostfold Hospital Trust
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Norway
- Age range
- From 9 Years to 14 Years
- Official registry ID
- NCT01220440
- Official title
Show the full official title
Comparing the Efficacy of Methylphenidate, Dextroamphetamine and Placebo in Children Diagnosed With ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Fredrikstad
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the effectiveness of Methylphenidate for people with ADHD.
Who is behind this study?
The study sponsor is Ostfold Hospital Trust, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Methylphenidate, Placebo and Dextroamphetamine.
Who was this study for?
Listed age limits: 9 years to 14 years.
